Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04294160
Title A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

colon cancer

rectum cancer

Therapies

Dabrafenib + LTT462 + Spartalizumab

Dabrafenib + LTT462 + TNO155

Dabrafenib + TNO155 + Trametinib

Dabrafenib + LTT462

Dabrafenib + LTT462 + LXH 254

Dabrafenib + LTT462 + Trametinib

Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST